SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-157874
Filing Date
2017-05-04
Accepted
2017-05-04 11:58:56
Documents
58
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d368298d10q.htm 10-Q 640540
2 EX-31.1 d368298dex311.htm EX-31.1 9142
3 EX-31.2 d368298dex312.htm EX-31.2 9113
4 EX-32.1 d368298dex321.htm EX-32.1 3483
5 EX-32.2 d368298dex322.htm EX-32.2 3440
  Complete submission text file 0001193125-17-157874.txt   3211896

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agio-20170331.xml EX-101.INS 492944
7 XBRL TAXONOMY EXTENSION SCHEMA agio-20170331.xsd EX-101.SCH 40871
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agio-20170331_cal.xml EX-101.CAL 48420
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agio-20170331_def.xml EX-101.DEF 146113
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20170331_lab.xml EX-101.LAB 322028
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20170331_pre.xml EX-101.PRE 243371
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 17812673
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences